41 |
HIV-1 Nef destabilisiert artifizielle Membransysteme: Untersuchung der Bedeutung des Myristoylankers und des positiven Ladungsclusters / HIV-1 Nef perturbs artificial membranes: investigation of the contribution of the myristoyl anchor and of the basic amino acid clusterSzilluweit, Ruth 28 April 2009 (has links)
No description available.
|
42 |
L'impact des cellules dendritiques dans la dérégulation des cellules B dans un contexte d'infection au virus d'immunodéficience humaineChagnon-Choquet, Josiane 12 1900 (has links)
Les cellules dendritiques (DC) sont parmi les premières cellules à rencontrer le virus d’immunodéficience humaine (VIH) au niveau des muqueuses. De plus, le fait que les DC sont, de manière directe ou indirecte par le virus et ses composantes, altérées tant par leur nombre, leur phénotype et leur fonction suggère leur implication dans les dérégulations des cellules B. Selon cette hypothèse, des études longitudinales impliquant des individus infectés au VIH-1 présentant différents profils de progression clinique menées dans notre laboratoire ont démontré que les altérations des cellules B sont concomitantes à une augmentation de l’expression de BLyS/BAFF dans le sang ainsi que par les DC myéloïdes (mDC) sanguines. De plus, lors de travaux antérieurs utilisant le modèle murin VIH-transgénique, les altérations des cellules B ont démontré une implication des DC et d’un excès de BLyS/BAFF, et ce, dépendamment du facteur négatif du VIH (Nef). Dans cette optique, nous investiguons dans cette présente étude l’implication de Nef dans la modulation du phénotype des DC ainsi que dans les dérégulations des cellules B. Chez tous les patients virémiques infectés au VIH-1, nous avons détecté la présence de Nef dans le plasma ainsi qu’au niveau des mDC et de leurs précurseurs d’origine monocytaire, tout au long du suivi de la progression clinique et au-delà de la thérapie antirétrovirale (ART). La surexpression de BLyS/BAFF est associée à la présence de Nef au niveau des mDC et de leur précurseur.. Des essais in vitro ont permis de démontrer l’induction d’un phénotype proinflammatoire par des mDC dérivés de monocytes lorsqu’en présence de Nef soluble, via l’augmentation de l’expression de BLyS/BAFF et de TNF-α, et où cet effet est bloqué par l’ajout de l’acide rétinoïque. Nos résultats suggèrent donc que Nef est impliquée dans le déclenchement et la persistance des dérégulations des cellules B retrouvées chez les individus infectés au VIH-1. Basé sur nos observations, une thérapie adjointe impliquant le blocage de BLyS/BAFF et/ou Nef pourrait contribuer au contrôle de l’inflammation et des altérations des cellules B. De plus, la quantification de Nef post-ART pourrait s’avérer utile dans l’évaluation du statut des réservoirs.
Précédemment, nous avons démontré que les dérégulations des cellules B sanguines de ces mêmes individus présentant un profil de progression rapide et classique sont accompagnées par l’augmentation de la fréquence d’une population partageant des caractéristiques des cellules B transitionnelles immatures (TI) et des cellules B de la zone marginale (ZM), que nous avons nommé les cellules B précurseur de la ZM. Toutefois, cette population est préservée chez les contrôleurs élites, chez qui nous avons trouvé une diminution significative de la fréquence des cellules B de la ZM présentant des marqueurs phénotypiques plus matures. Récemment, ces cellules ont été associées à un potentiel de fonction régulatrice (Breg), motivant ainsi notre poursuite, dans cette étude, de la caractérisation de ces cellules B. Comme pour les individus non infectés au VIH-1, nous avons démontré que les cellules B matures de la ZM contrôlent leur capacité de production d’IL-10 chez les contrôleurs élites, contrairement à une augmentation chez les progresseurs rapides et classiques. Aussi, les cellules B précurseur de la ZM des contrôleurs élites fournissent une expression importante de LT-α lorsque comparés aux individus non infectés au VIH-1, alors que cet apport de LT-α est attribué aux cellules B TI chez les progresseurs. Le contrôle de la progression clinique semble associé à un ratio en faveur de LT-α vs IL-10 au niveau des cellules B précurseur de la ZM. Nos résultats suggèrent qu’un maintien de l’intégrité du potentiel régulateur ainsi qu’une expression augmentée de LT-α par les cellules B de première ligne, telles les populations de la ZM, sont impliqués dans le contrôle de la progression clinique du VIH-1, possiblement par leur contribution à la modulation et l’homéostasie immunitaire. De telles populations doivent être considérées lors de l’élaboration de vaccins, ces derniers cherchant à générer une réponse protectrice de première ligne et adaptative. / In the context of HIV-1 infection, DC are amongst the first cells to encounter the virus at the mucosal surfaces, and are directly and indirectly affected by the virus or its components. The fact that DC are altered in number, phenotype and function in the context of HIV, suggest they may be involved in driving B cell dysregulations, which occur as early as in the acute phase of HIV-infection and are not fully restored by therapy. As such, in recent longitudinal studies involving HIV-infected individuals with different rates of disease progression, we have shown that B cell dysregulations were associated with increased BLyS/BAFF expression in plasma and by blood myeloid DC (mDC). In previous work with HIV-transgenic mice, B cell dysregulations involved DC, excess BLyS/BAFF and were dependant on the HIV negative factor (Nef). We therefore aim to investigate the impact of HIV-Nef in modulating DC phenotype and B cell dysregulations. Blood samples from the same HIV-infected individuals as mentioned above were studied, following the identical longitudinal scheme. HIV-Nef was detected in plasma and beared by blood mDC and mDC precursors of all viremic HIV-infected patients, throughout follow-up and beyond therapy. Detection of HIV-Nef in mDC and their precursors was associated with BLyS/BAFF over-expression. In vitro, soluble HIV-Nef drove monocyte-derived mDC towards a pro-inflammatory phenotype by increasing the expression of BLyS/BAFF and TNF-α. Futhermore, this effect was blocked by the addition of retinoic acid. These data suggest that HIV-Nef is involved in the driving and persistence of B cell dysregulations in HIV-infected individuals. Based on our observations, therapeutic blocking of BLyS/BAFF and/or Nef could help control inflammation and B cell disorders. Moreover, measurement of HIV-Nef post-therapy may be useful in assessing reservoir status.
We have previously shown that B cell dysregulations in the blood of HIV-infected rapid and classic progressors were accompanied by the increased frequency of a population presenting characteristics of both transitional immature (TI) and marginal zone (MZ) B cells, which we have termed “MZ-like precursors”. However, this population was unaltered in ELITE controllers (EC), even though we found significantly lower frequencies of more mature MZ-like B cells. These results suggest that such first line B cell populations may be involved in the battle against HIV-1. Interestingly, MZ-like B cell populations have recently been associated with Breg potential. As such, we found that as for HIV negative individuals, mature MZ-like B cells control their capacity of IL-10 production in EC. In contrast, HIV-1-infected rapid and classic progressors presented increased relative frequencies of MZ-like B cells expressing IL-10. Interestingly, in EC, blood MZ-like precursors provided substantial LT-α expression when compared to HIV negative individuals, and in contrast to that found in rapid and classic progressors, where significant LT-α expression was provided by TI B cells. In fact, the degree of control of disease progression seems associated with greater LT-α to IL-10 ratio within the MZ-like precursors population. Our results therefore suggest that maintenance of Breg integrity and increased LT-α expression by first line B cells, such as MZ-like populations, is involved in the control of HIV-1 disease progression, possibly trough contribution to immune modulation and homeostasis. Soliciting such populations should be beared in mind in the design of vaccine strategies aiming at generating both first line and adaptive protective responses.
|
43 |
Théorèmes d'annulation et théorèmes de structure sur les variétés kähleriennes compactesCao, Junyan 18 September 2013 (has links) (PDF)
L'objet principal de cette thèse est de généraliser un certain nombre de résultats bien connus de la géométrie algébrique au cas kählerien non nécessairement projectif. On généralise d'abord le théorème d'annulation de Nadel au cas kählerien arbitraire. On obtient aussi un cas particulier du théorème d'annulation de Kawamata-Viehweg pour les variétés qui admettent une fibration vers un tore dont la fibre générique est projective. En utilisant ce résultat, on étudie le problème de déformation pour les variétés kählériennes compactes sous une hypothèse portant sur leurs fibrés canoniques. On étudie enfin les variétés à fibré anticonique nef. On montre que si le fibré anticanonique est nef, alors le fibré tangent est à pentes semi-positif relative à la filtration de Harder-Narasimhan pour la polarization $\omega_X ^{n-1}$. Comme application, on donne une preuve simple de la surjectivité de l'application d'Albanese, et on étudie aussi la trivialité locale de l'application d'Albanese.
|
44 |
Investigating the Roles of NEDD4.2s and Nef in the Release and Replication of HIV-1: A DissertationWeiss, Eric R. 13 September 2012 (has links)
Replication of HIV-1 requires the assembly and release of mature and infectious viral particles. In order to accomplish this goal, HIV-1 has evolved multiple methods to interact with the host cell. HIV-1 recruits the host cell ESCRT machinery to facilitate the release of nascent viral particles from the host cell membrane. Recruitment of these cellular factors is dependent on the presence of short motifs in Gag referred to as Late-domains. Deletion or mutation of these domains results in substantial decrease in the release of infectious virions. However, previously published work has indicated that over-expression of the E3 ubiquitin ligase, NEDD4.2s is able to robustly rescue release of otherwise budding-defective HIV-1 particles. This rescue is specific to the NEDD4.2s isoform as related E3 ubiquitin ligases display no ability to rescue particle release. In addition, rescue of particle release is dependent on the presence of the partial C2 domain and a catalytically active HECT domain of NEDD4.2s. Here I provide evidence supporting the hypothesis that a partial C2 domain of NEDD4.2s constitutes a Gag interacting module capable of targeting the HECT domains of other E3 ubiquitin ligases to HIV-1 Gag. Also, by generating chimeras between HECT domains shown to form poly-ubiquitin chains linked through either K48 or K63 of ubiquitin, I demonstrate that the ability of NEDD4.2s to catalyze the formation of K63-polyubiquitin chains is required for its stimulation of HIV-1 L-domain mutant particle release. In addition, I present findings from on-going research into the role of the HIV-1 accessory protein Nef during viral replication using the culture T-cell line, MOLT3. My current findings indicate that downregulation of CD4 from the host cell membrane does not solely account for the dramatic dependence of HIV-1 replication on Nef expression in this system. In addition, I present evidence indicating that Nef proteins from diverse HIV-1 Groups and strains are capable of enhancing HIV-1 replication in this system. Analysis of a range of mutations in Nef known to impact interaction with cellular proteins suggest that the observed replication enhancement requires Nef targeting to the host cell membrane and may also require the ability to interact with select Src-kinases. Lastly, we find that the ability of Nef to enhance replication in this system is separate from any increase in viral particle infectivity, in agreement with current literature.
|
45 |
Étude de l’impact des niveaux élevés de BAFF sur la dérégulation des lymphocytes B de la zone marginale associée avec l’infection au virus de l’immunodéficience humaineByrns, Michelle 12 1900 (has links)
L’infection au VIH a plusieurs effets délétères, dont la dérégulation du compartiment des lymphocytes B. Cette dérégulation s’installe rapidement après l’infection et perdure au-delà de la thérapie antirétrovirale, pouvant mener à diverses maladies auto-immunes ainsi qu’à des lymphomes. Chez les individus atteints du VIH, cette dérégulation mène à l’augmentation de la fréquence des cellules B précurseurs de la zone marginale (MZ) dans le sang ainsi qu’à leur production d’IL-10, à l’augmentation du B-cell activating factor (BAFF), et à l’hyperglobulinémie. De plus, Nef a été détecté dans le sérum et dans les cellules dendritiques des patients infectés, les niveaux de Nef des patients corrélant avec leurs niveaux de BAFF.
L’analyse d’un RNAseq effectué sur des cellules B MZ précurseurs démontre la diminution hautement significative d’expression des NR4As et de CD83 chez les patients VIH+ progresseurs comparativement aux contrôles VIH- et aux élites contrôleurs. Notre équipe a d’ailleurs démontré le potentiel et la fonction Breg associés à l’expression des NR4As et CD83 chez les cellules B MZ précurseurs du sang et d’amygdales. Aussi, la majorité de cette population co-exprime CD73 et CD39, molécules impliquées dans la synthèse de l’adénosine, cette dernière ayant un contrôle sur l’expression des NR4As.
Nous voulions donc étudier l’effet de niveaux élevés de BAFF et de Nef sur la modulation de l’expression des NR4As, de CD83, CD73 et CD39 chez les cellules B MZ d'amygdales et l’effet de la déhydroergotamine (DHE) sur ce modèle, des études ayant déjà illustré sa modulation positive des NR4As. Nous étions aussi intéressés par la production d’IL-10 par ces cellules B MZ ainsi que l’effet de Nef sur son expression. Nous avons trouvé qu’après incubation avec BAFF et Nef, l’expression de NR4A1 et de CD83 était souvent plus basse qu’après une incubation avec BAFF seul qui semblait augmenter l’expression de ces dernières, ce qui concorde avec les résultats du RNAseq mentionné plus haut. Après une incubation avec Nef seul, l’expression des NR4As et de CD83 est similaire à l’expression mesurée après une incubation sans traitement, mais certains patients ont démontré une diminution légère de l’expression de ces molécules, chose normale puisque les échantillons contenaient tous des niveaux basaux de BAFF. De plus, nos résultats démontrent que le DHE augmente l’expression de NR4A1 et 3 après que leur expression ait été diminuée par Nef et son effet semble être plus important au niveau des cellules B MZ et MZ précurseurs. Ces résultats suggèrent l’utilité du DHE pour la diminution des niveaux inflammatoires chez les individus atteints du VIH, les NR4As ayant un rôle anti-inflammatoire par la diminution des fréquences de NFkB, molécule modulée positivement par Nef. Nous avons remarqué que les populations exprimant IL-10 co-expriment principalement CD10. L’effet de Nef n’a malheureusement pas été remarqué sur l’expression d’IL-10, d’autres études étant nécessaires avec nos populations d’amygdales. Bref, nos résultats suggèrent l’utilité d’agents thérapeutiques ciblant les NR4As en addition à la thérapie antirétrovirale, leur modulation chez les lymphocytes B MZ et MZ précurseurs pouvant être un aspect clé du contrôle des niveaux inflammatoires chez les individus atteints du VIH. / HIV infection is accompanied by many deleterious effects, including B cell
dysfunction. This dysfunction begins rapidly after infection and persists throughout the
course of infection, without being fully restored by antiretroviral therapy. These alterations
can lead to lymphomas and a multitude of auto-immune diseases. In people living with
HIV, B-cell deregulation leads to an increase in “precursor-like” marginal zone (MZ) B
cell frequency and their secretion of IL-10, to an increase in B-cell activating factor
(BAFF), and to hyperglobulinemia. In addition, Nef has been detected in the serum and
dendritic cells of infected individuals, its levels correlating with BAFF levels in affected
patients.
The analysis of an RNA-seq performed on precursor-like MZ B cells indicated a
highly significant drop in NR4A1-3 and CD83 levels in HIV+ progressors compared to
HIV- controls and HIV+ elite controllers. In fact, our team has previously demonstrated
regulatory “Breg” potential associated to NR4A and CD83 expression in blood and tonsil
precursor-like MZ B cells. The majority of this population also co-expresses CD73 and
CD39, molecules involved in adenosine synthesis, adenosine being a regulator of NR4A
expression.
Therefore, we wanted to study the effects of BAFF and Nef on the modulation of
NR4A, CD83, CD73 and CD39 expression in tonsil MZ B cells as well as the effect of
dihydroergotamine (DHE) on this model, studies having already shown its positive
modulation on the NR4As. We were also interested in the effects of Nef on IL-10
production by MZ B cells. We found that after incubation with BAFF and Nef, NR4A1
and CD83 expression was often lower than after an incubation with BAFF only, which
seemed to increase their expression. This corresponds with the results of the RNA-seq
mentioned above. After incubation with Nef alone, NR4A and CD83 expression is similar
to the expression levels found after incubation without treatment. Some patients did
demonstrate a slight decrease in the expression of these molecules, a normal observation
considering all samples contain a basal level of BAFF. In addition, our results demonstrate
that DHE increases NR4A1 and NR4A3 levels after their expression is initially decreased
iv
by Nef, and its effect seems more significant in MZ and precursor-like MZ B cells. These
results suggest the usefulness of DHE for the reduction of inflammatory levels in
individuals living with HIV, the NR4As having an anti-inflammatory role by decreasing
the frequency of NFkB, a molecule positively modulated by Nef. Furthermore, we noted
the populations expressing IL-10 mainly co-express CD10. Unfortunately, Nef’s
previously reported effect on IL-10 expression was not noticed, indicating the need for
further studies using our tonsil samples. In conclusion, our results suggest the value of
therapeutic agents targeting NR4As in addition to antiretroviral therapy, their modulation
of MZ and precursor-like MZ B cells possibly being the key to controlling inflammatory
levels in individuals living with HIV.
|
46 |
O envolvimento da proteína adaptadora 1 (AP-1) no mecanismo de regulação negativa do receptor CD4 por Nef de HIV-1 / The involvement of Adaptor Protein 1 (AP-1) on the Mechanism of CD4 Down-regulation by Nef from HIV-1Tavares, Lucas Alves 05 August 2016 (has links)
O Vírus da Imunodeficiência Humana (HIV) é o agente etiológico da Síndrome da Imunodeficiência Adquirida (AIDS). A AIDS é uma doença de distribuição mundial, e estima-se que existam atualmente pelo menos 36,9 milhões de pessoas infectadas com o vírus. Durante o seu ciclo replicativo, o HIV promove diversas alterações na fisiologia da célula hospedeira a fim de promover sua sobrevivência e potencializar a replicação. A rápida progressão da infecção pelo HIV-1 em humanos e em modelos animais está intimamente ligada à função da proteína acessória Nef. Dentre as diversas ações de Nef está a regulação negativa de proteínas importantes na resposta imunológica, como o receptor CD4. Sabe-se que esta ação resulta da indução da degradação de CD4 em lisossomos, mas os mecanismos moleculares envolvidos ainda são totalmente elucidados. Nef forma um complexo tripartite com a cauda citosólica de CD4 e a proteína adaptadora 2 (AP-2), em vesículas revestidas por clatrina nascentes, induzindo a internalização e degradação lisossomal de CD4. Pesquisas anteriores demonstraram que o direcionamento de CD4 aos lisossomos por Nef envolve a entrada do receptor na via dos corpos multivesiculares (MVBs), por um mecanismo atípico, pois, embora não necessite da ubiquitinação de carga, depende da ação de proteínas que compõem os ESCRTs (Endosomal Sorting Complexes Required for Transport) e da ação de Alix, uma proteína acessória da maquinaria ESCRT. Já foi reportado que Nef interage com subunidades dos complexos AP-1, AP-2, AP-3 e Nef não parece interagir com subunidades de AP-4 e AP-5. Entretanto, o papel da interação de Nef com AP-1 e AP-3 na regulação negativa de CD4 ainda não está totalmente elucidado. Ademais, AP-1, AP-2 e AP-3 são potencialmente heterogêneos devido à existência de isoformas múltiplas das subunidades codificadas por diferentes genes. Todavia, existem poucos estudos para demonstrar se as diferentes combinações de isoformas dos APs são formadas e se possuem propriedades funcionais distintas. O presente trabalho procurou identificar e caracterizar fatores celulares envolvidos na regulação do tráfego intracelular de proteínas no processo de regulação negativa de CD4 induzido por Nef. Mais especificamente, este estudo buscou caracterizar a participação do complexo AP-1 na modulação negativa de CD4 por Nef de HIV-1, através do estudo funcional das duas isoformas de ?-adaptina, subunidades de AP-1. Utilizando a técnica de Pull-down demonstramos que Nef é capaz de interagir com ?2. Além disso, nossos dados de Imunoblot indicaram que a proteína ?2-adaptina, e não ?1-adaptina, é necessária no processo de degradação lisossomal de CD4 por Nef e que esta participação é conservada para degradação de CD4 por Nef de diferentes cepas virais. Ademais, por citometria de fluxo, o silenciamento de ?2, e não de ?1, compromete a diminuição dos níveis de CD4 por Nef da membrana plasmática. A análise por imunofluorêsncia indireta também revelou que a diminuição dos níveis de ?2 impede a redistribuição de CD4 por Nef para regiões perinucleares, acarretando no acúmulo de CD4, retirados por Nef da membrana plasmática, em endossomos primários. A depleção de ?1A, outra subunidade de AP-1, acarretou na diminuição dos níveis celulares de ?2 e ?1, bem como, no comprometimento da eficiente degradação de CD4 por Nef. Além disso, foi possível observar que, ao perturbar a maquinaria ESCRT via super-expressão de HRS (uma subunidade do complexo ESCRT-0), ocorreu um acumulo de ?2 em endossomos dilatados contendo HRS-GFP, nos quais também detectou-se CD4 que foi internalizado por Nef. Em conjunto, os resultados indicam que ?2-adaptina é uma importante molécula para o direcionamento de CD4 por Nef para a via ESCRT/MVB, mostrando ser uma proteína relevante no sistema endo-lisossomal. Ademais, os resultados indicaram que as isoformas ?-adaptinas não só possuem funções distintas, mas também parecem compor complexos AP-1 com diferentes funções celulares, já que apenas a variante AP-1 contendo ?2, mas não ?1, participa da regulação negativa de CD4 por Nef. Estes estudos contribuem para o melhor entendimento dos mecanismos moleculares envolvidos na atividade de Nef, que poderão também ajudar na melhor compreensão da patogênese do HIV e da síndrome relacionada. Em adição, este trabalho contribui para o entendimento de processos fundamentais da regulação do tráfego de proteínas transmembrana no sistema endo-lisossomal. / The Human Immunodeficiency Virus (HIV) is the etiologic agent of Acquired Immunodeficiency Syndrome (AIDS). AIDS is a disease which has a global distribution, and it is estimated that there are currently at least 36.9 million people infected with the virus. During the replication cycle, HIV promotes several changes in the physiology of the host cell to promote their survival and enhance replication. The fast progression of HIV-1 in humans and animal models is closely linked to the function of an accessory protein Nef. Among several actions of Nef, one is the most important is the down-regulation of proteins from the immune response, such as the CD4 receptor. It is known that this action causes CD4 degradation in lysosome, but the molecular mechanisms are still incompletely understood. Nef forms a tripartite complex with the cytosolic tail of the CD4 and adapter protein 2 (AP-2) in clathrin-coated vesicles, inducing CD4 internalization and lysosome degradation. Previous research has demonstrated that CD4 target to lysosomes by Nef involves targeting of this receptor to multivesicular bodies (MVBs) pathway by an atypical mechanism because, although not need charging ubiquitination, depends on the proteins from ESCRTs (Endosomal Sorting Complexes Required for Transport) machinery and the action of Alix, an accessory protein ESCRT machinery. It has been reported that Nef interacts with subunits of AP- 1, AP-2, AP-3 complexes and Nef does not appear to interact with AP-4 and AP-5 subunits. However, the role of Nef interaction with AP-1 or AP-3 in CD4 down-regulation is poorly understood. Furthermore, AP-1, AP-2 and AP-3 are potentially heterogeneous due to the existence of multiple subunits isoforms encoded by different genes. However, there are few studies to demonstrate if the different combinations of APs isoforms are form and if they have distinct functional properties. This study aim to identify and characterize cellular factors involved on CD4 down-modulation induced by Nef from HIV-1. More specifically, this study aimed to characterize the involvement of AP-1 complex in the down-regulation of CD4 by Nef HIV-1 through the functional study of the two isoforms of ?-adaptins, AP-1 subunits. By pull-down technique, we showed that Nef is able to interact with ?2. In addition, our data from immunoblots indicated that ?2- adaptin, not ?1-adaptin, is required in Nef-mediated targeting of CD4 to lysosomes and the ?2 participation in this process is conserved by Nef from different viral strains. Furthermore, by flow cytometry assay, ?2 depletion, but not ?1 depletion, compromises the reduction of surface CD4 levels induced by Nef. Immunofluorescence microscopy analysis also revealed that ?2 depletion impairs the redistribution of CD4 by Nef to juxtanuclear region, resulting in CD4 accumulation in primary endosomes. Knockdown of ?1A, another subunit of AP-1, resulted in decreased cellular levels of ?1 and ?2 and, compromising the efficient CD4 degradation by Nef. Moreover, upon artificially stabilizing ESCRT-I in early endosomes, via overexpression of HRS, internalized CD4 accumulates in enlarged HRS-GFP positive endosomes, where co-localize with ?2. Together, the results indicate that ?2-adaptin is a molecule that is essential for CD4 targeting by Nef to ESCRT/MVB pathway, being an important protein in the endo-lysosomal system. Furthermore, the results indicate that ?-adaptins isoforms not only have different functions, but also seem to compose AP-1 complex with distinct cell functions, and only the AP-1 variant comprising ?2, but not ?1, acts in the CD4 down-regulation induced by Nef. These studies contribute to a better understanding on the molecular mechanisms involved in Nef activities, which may also help to improve the understanding of the HIV pathogenesis and the related syndrome. In addition, this work contributes with the understanding of primordial process regulation on intracellular trafficking of transmembrane proteins.
|
47 |
O envolvimento da proteína adaptadora 1 (AP-1) no mecanismo de regulação negativa do receptor CD4 por Nef de HIV-1 / The involvement of Adaptor Protein 1 (AP-1) on the Mechanism of CD4 Down-regulation by Nef from HIV-1Lucas Alves Tavares 05 August 2016 (has links)
O Vírus da Imunodeficiência Humana (HIV) é o agente etiológico da Síndrome da Imunodeficiência Adquirida (AIDS). A AIDS é uma doença de distribuição mundial, e estima-se que existam atualmente pelo menos 36,9 milhões de pessoas infectadas com o vírus. Durante o seu ciclo replicativo, o HIV promove diversas alterações na fisiologia da célula hospedeira a fim de promover sua sobrevivência e potencializar a replicação. A rápida progressão da infecção pelo HIV-1 em humanos e em modelos animais está intimamente ligada à função da proteína acessória Nef. Dentre as diversas ações de Nef está a regulação negativa de proteínas importantes na resposta imunológica, como o receptor CD4. Sabe-se que esta ação resulta da indução da degradação de CD4 em lisossomos, mas os mecanismos moleculares envolvidos ainda são totalmente elucidados. Nef forma um complexo tripartite com a cauda citosólica de CD4 e a proteína adaptadora 2 (AP-2), em vesículas revestidas por clatrina nascentes, induzindo a internalização e degradação lisossomal de CD4. Pesquisas anteriores demonstraram que o direcionamento de CD4 aos lisossomos por Nef envolve a entrada do receptor na via dos corpos multivesiculares (MVBs), por um mecanismo atípico, pois, embora não necessite da ubiquitinação de carga, depende da ação de proteínas que compõem os ESCRTs (Endosomal Sorting Complexes Required for Transport) e da ação de Alix, uma proteína acessória da maquinaria ESCRT. Já foi reportado que Nef interage com subunidades dos complexos AP-1, AP-2, AP-3 e Nef não parece interagir com subunidades de AP-4 e AP-5. Entretanto, o papel da interação de Nef com AP-1 e AP-3 na regulação negativa de CD4 ainda não está totalmente elucidado. Ademais, AP-1, AP-2 e AP-3 são potencialmente heterogêneos devido à existência de isoformas múltiplas das subunidades codificadas por diferentes genes. Todavia, existem poucos estudos para demonstrar se as diferentes combinações de isoformas dos APs são formadas e se possuem propriedades funcionais distintas. O presente trabalho procurou identificar e caracterizar fatores celulares envolvidos na regulação do tráfego intracelular de proteínas no processo de regulação negativa de CD4 induzido por Nef. Mais especificamente, este estudo buscou caracterizar a participação do complexo AP-1 na modulação negativa de CD4 por Nef de HIV-1, através do estudo funcional das duas isoformas de ?-adaptina, subunidades de AP-1. Utilizando a técnica de Pull-down demonstramos que Nef é capaz de interagir com ?2. Além disso, nossos dados de Imunoblot indicaram que a proteína ?2-adaptina, e não ?1-adaptina, é necessária no processo de degradação lisossomal de CD4 por Nef e que esta participação é conservada para degradação de CD4 por Nef de diferentes cepas virais. Ademais, por citometria de fluxo, o silenciamento de ?2, e não de ?1, compromete a diminuição dos níveis de CD4 por Nef da membrana plasmática. A análise por imunofluorêsncia indireta também revelou que a diminuição dos níveis de ?2 impede a redistribuição de CD4 por Nef para regiões perinucleares, acarretando no acúmulo de CD4, retirados por Nef da membrana plasmática, em endossomos primários. A depleção de ?1A, outra subunidade de AP-1, acarretou na diminuição dos níveis celulares de ?2 e ?1, bem como, no comprometimento da eficiente degradação de CD4 por Nef. Além disso, foi possível observar que, ao perturbar a maquinaria ESCRT via super-expressão de HRS (uma subunidade do complexo ESCRT-0), ocorreu um acumulo de ?2 em endossomos dilatados contendo HRS-GFP, nos quais também detectou-se CD4 que foi internalizado por Nef. Em conjunto, os resultados indicam que ?2-adaptina é uma importante molécula para o direcionamento de CD4 por Nef para a via ESCRT/MVB, mostrando ser uma proteína relevante no sistema endo-lisossomal. Ademais, os resultados indicaram que as isoformas ?-adaptinas não só possuem funções distintas, mas também parecem compor complexos AP-1 com diferentes funções celulares, já que apenas a variante AP-1 contendo ?2, mas não ?1, participa da regulação negativa de CD4 por Nef. Estes estudos contribuem para o melhor entendimento dos mecanismos moleculares envolvidos na atividade de Nef, que poderão também ajudar na melhor compreensão da patogênese do HIV e da síndrome relacionada. Em adição, este trabalho contribui para o entendimento de processos fundamentais da regulação do tráfego de proteínas transmembrana no sistema endo-lisossomal. / The Human Immunodeficiency Virus (HIV) is the etiologic agent of Acquired Immunodeficiency Syndrome (AIDS). AIDS is a disease which has a global distribution, and it is estimated that there are currently at least 36.9 million people infected with the virus. During the replication cycle, HIV promotes several changes in the physiology of the host cell to promote their survival and enhance replication. The fast progression of HIV-1 in humans and animal models is closely linked to the function of an accessory protein Nef. Among several actions of Nef, one is the most important is the down-regulation of proteins from the immune response, such as the CD4 receptor. It is known that this action causes CD4 degradation in lysosome, but the molecular mechanisms are still incompletely understood. Nef forms a tripartite complex with the cytosolic tail of the CD4 and adapter protein 2 (AP-2) in clathrin-coated vesicles, inducing CD4 internalization and lysosome degradation. Previous research has demonstrated that CD4 target to lysosomes by Nef involves targeting of this receptor to multivesicular bodies (MVBs) pathway by an atypical mechanism because, although not need charging ubiquitination, depends on the proteins from ESCRTs (Endosomal Sorting Complexes Required for Transport) machinery and the action of Alix, an accessory protein ESCRT machinery. It has been reported that Nef interacts with subunits of AP- 1, AP-2, AP-3 complexes and Nef does not appear to interact with AP-4 and AP-5 subunits. However, the role of Nef interaction with AP-1 or AP-3 in CD4 down-regulation is poorly understood. Furthermore, AP-1, AP-2 and AP-3 are potentially heterogeneous due to the existence of multiple subunits isoforms encoded by different genes. However, there are few studies to demonstrate if the different combinations of APs isoforms are form and if they have distinct functional properties. This study aim to identify and characterize cellular factors involved on CD4 down-modulation induced by Nef from HIV-1. More specifically, this study aimed to characterize the involvement of AP-1 complex in the down-regulation of CD4 by Nef HIV-1 through the functional study of the two isoforms of ?-adaptins, AP-1 subunits. By pull-down technique, we showed that Nef is able to interact with ?2. In addition, our data from immunoblots indicated that ?2- adaptin, not ?1-adaptin, is required in Nef-mediated targeting of CD4 to lysosomes and the ?2 participation in this process is conserved by Nef from different viral strains. Furthermore, by flow cytometry assay, ?2 depletion, but not ?1 depletion, compromises the reduction of surface CD4 levels induced by Nef. Immunofluorescence microscopy analysis also revealed that ?2 depletion impairs the redistribution of CD4 by Nef to juxtanuclear region, resulting in CD4 accumulation in primary endosomes. Knockdown of ?1A, another subunit of AP-1, resulted in decreased cellular levels of ?1 and ?2 and, compromising the efficient CD4 degradation by Nef. Moreover, upon artificially stabilizing ESCRT-I in early endosomes, via overexpression of HRS, internalized CD4 accumulates in enlarged HRS-GFP positive endosomes, where co-localize with ?2. Together, the results indicate that ?2-adaptin is a molecule that is essential for CD4 targeting by Nef to ESCRT/MVB pathway, being an important protein in the endo-lysosomal system. Furthermore, the results indicate that ?-adaptins isoforms not only have different functions, but also seem to compose AP-1 complex with distinct cell functions, and only the AP-1 variant comprising ?2, but not ?1, acts in the CD4 down-regulation induced by Nef. These studies contribute to a better understanding on the molecular mechanisms involved in Nef activities, which may also help to improve the understanding of the HIV pathogenesis and the related syndrome. In addition, this work contributes with the understanding of primordial process regulation on intracellular trafficking of transmembrane proteins.
|
48 |
Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunctionWang, Ting January 2014 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / With effective antiretroviral therapy (ART), cardiovascular diseases (CVD), are emerging as a major cause of morbidity and death in the aging population with HIV infection. Although this increase in CVD could be partially explained by the toxic effects of combined anti-retroviral therapy (ART), more recently, HIV infection has emerged as an independent risk factor for CVD. However, it is unclear how HIV can contribute to CVD in patients on ART, when viral titers are low or non-detectable. Here, we provide several lines of evidence that HIV-Nef, produced in infected cells even when virus production is halted by ART, can lead to endothelial activation and dysfunction, and thus may be involved in CVD. We demonstrate that HIV-infected T cell-induced endothelial cell activation requires direct contact as well as functional HIV-Nef. Nef protein from either HIV-infected or Nef-transfected T cells rapidly transfers to endothelial cells while inducing nanotube-like conduits connecting T cells to endothelial cells. This transfer or transfection of endothelial cells results in endothelial apoptosis, ROS generation and release of monocyte attractant protein-1 (MCP-1). A Nef SH3 binding site mutant abolishes Nef-induced apoptosis and ROS formation and reduces MCP-1 production in endothelial cells, suggesting that the Nef SH3 binding site is critical for Nef effects on endothelial cells. Nef induces apoptosis of endothelial cells through both NADPH oxidase- and ROS-dependent mechanisms, while Nef-induced MCP-1 production is NF-kB dependent. Importantly, Nef can be found in CD4 positive and bystander circulating blood cells in patients receiving virally suppressive ART, and in the endothelium of chimeric SIV-infected macaques. Together, these data indicate that Nef could exert pro-atherogenic effects on the endothelium even when HIV infection is controlled and that inhibition of Nef-associated pathways may be promising new therapeutic targets for reducing the risk for cardiovascular disease in the HIV-infected population.
|
Page generated in 0.0182 seconds